Malakoff – FRANCE, August 29th, 2017 – THERACLION (Alternext, FR0010120402 – ALTHE, PEA PME eligible), a company specialized in leading-edge medical equipment for echotherapy, today announces the results published in the « Radiology » journal on Graves’ disease treatment by echotherapy using Echopulse.
The study is entitled : “Single-Session High-Intensity Focused Ultrasound Treatment for Persistent or Relapsed Graves’ Disease : Preliminary Experience in a Prospective Study” and is available online on PubMed.